missing translation for 'onlineSavingsMsg'
Learn More
Learn More
beta-2 Microglobulin Monoclonal Antibody (B2M-01), PE, Invitrogen™
Mouse Monoclonal Antibody
Brand: Invitrogen A15770
This item is not returnable.
View return policy
Description
Beta-2-microglobulin (B2M) is a 12-14 kDa protein that is a subunit of the major histocompatibility complex (MHC) class I. Human beta 2 Microglobulin associated with HLA Class I antigens are expressed on many types of cells including lymphocytes, thymocytes, monocytes, granulocytes, platelets, endothelial cells, and epithelial cells, but is absent on erythrocytes. Beta-2 microglobulin is also found in free form in the plasma. The amino acid sequence of Beta-2-microglobulin is homologous to the constant regions of immunoglobulin heavy and light chains, with a predomitly beta pleated sheet structure. The protein is ubiquitously expressed in the cytoplasm, and is involved in antigen processing and presentation. Beta-2-microglobulin also plays a role in TCR signaling, and downstream signaling in naive CD8+ cells. Beta 2-microglobulin is encoded by the B2M gene located on chromosome 15. A mutation in the Beta-2-microglobulin gene has been shown to result in hypercatabolic hypoproteinemia. Levels of beta 2 microglobulin can be used to assess renal function in kidney transplant recipients. Beta-2-microglobulin that protein can be used as a prognostic marker for HIV infection.
Specifications
| beta-2 Microglobulin | |
| Monoclonal | |
| 0.1 mg/mL | |
| PBS with 0.2% BSA and 15mM sodium azide | |
| P61769 | |
| B2M | |
| human beta2-microglobulin. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG2a |
| Flow Cytometry | |
| B2M-01 | |
| PE | |
| B2M | |
| B2-microglobulin, B2M, CDABP0092, HDCMA22P, beta chain MHC class I molecules, MHC Class 1 beta | |
| Mouse | |
| Purified | |
| RUO | |
| 567 | |
| 4° C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction